NCT07115706View on ClinicalTrials.gov

JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

Not yet recruitingOBSERVATIONAL
Enrollment

7,150

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Erosive Gastroesophageal Reflux Disease
Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY

NCT07115706 - JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD | Biotech Hunter | Biotech Hunter